Search

everythinglearnresearchcommunity

for

Search:↓

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Understanding skin reactions to radiation has improved, helping to reduce injuries and prevent skin cancer.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Olive mill wastewater can be used as a sustainable source of skin-benefiting ingredients.

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Chemical hair straighteners can cause scalp and hair damage, but long-term effects are unclear.

Rural Bangladeshi girls mature later than peers in other low and middle-income countries due to poor nutrition and socioeconomic conditions.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Burn injuries can cause long-term itching, skin color changes, and cancer risks, needing personalized treatment.

Finasteride may cause depression and suicidal thoughts, especially in young men.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

FGF-7 helps hair grow by activating hair follicles and is a promising target for hair loss treatments.

Age and diabetes are linked to larger trichilemmal cysts, while hypertension is linked to smaller ones.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

MC1R gene variations affect skin, hair color, UV sensitivity, and melanoma risk.

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Androgenetic alopecia may be linked to metabolic syndrome.

Girls conceived via assisted reproductive technologies show early puberty signs and larger ovaries.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

High-quality data on skin cancer is crucial for understanding its trends and allocating healthcare resources effectively.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.